I think the risks re reimbursement in the EU were always underplayed .
Yep, by the company and this board. I remember how furious the board generally was with Wall Street for not "properly" valuing the EU opportunity. The company still pushes 1 billion plus for the EU and yet can't report a single dollar from there.